newsfilter
← Latest News
PR Newswire·

BiondVax Announces First Quarter 2022 Financial Results and Provides Business Update

JERUSALEM, June 1, 2022 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (NASDAQ:BVXV), a biopharmaceuticals company focused on developing, manufacturing and commercializing innovative products for the prevention and treatment of infectious diseases and o